[
  {
    "ts": null,
    "headline": "Cantor Fitzgerald Reiterates a Buy Rating on Elevance Health (ELV), Keeps the PT",
    "summary": "​Elevance Health, Inc. (NYSE:ELV) is one of the Most Undervalued Long Term Stocks to Buy Right Now. On October 21, Sarah James from Cantor Fitzgerald reiterated a Buy rating on Elevance Health, Inc. (NYSE:ELV) with a price target of $400. ​The firm maintains a cautious outlook on the 2026 Medicaid Environment, noting that the company […]",
    "url": "https://finnhub.io/api/news?id=3439a82bb1f7e12f6152093346f50805e7fab12913b6dc811bdcc868facaa4ef",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761477916,
      "headline": "Cantor Fitzgerald Reiterates a Buy Rating on Elevance Health (ELV), Keeps the PT",
      "id": 137216870,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "​Elevance Health, Inc. (NYSE:ELV) is one of the Most Undervalued Long Term Stocks to Buy Right Now. On October 21, Sarah James from Cantor Fitzgerald reiterated a Buy rating on Elevance Health, Inc. (NYSE:ELV) with a price target of $400. ​The firm maintains a cautious outlook on the 2026 Medicaid Environment, noting that the company […]",
      "url": "https://finnhub.io/api/news?id=3439a82bb1f7e12f6152093346f50805e7fab12913b6dc811bdcc868facaa4ef"
    }
  }
]